Who REALLY REALLY cared about my Pfizer stories?
It's always fun to check who's coming by. After all, if no one did, it would feel pretty lonely. So the more the merrier.
And it shouldn't come as a surprise that the past week has been one of the busiest ever, based on number of visitors.
It probably also shouldn't be a surprise that the number one visitor was Pfizer. Close to 10,000 visits in a week. Wow. Seems like everyone must talk about the India affair and the maraviroc premarketing allegations over at Big Blue.
But what about the rest, who else cared about my Pfizer stories?
Some interesting stuff there. Lot's of biotech companies doing deals with Pfizer. I guess they may realize that Pfizer is spying on them too. Also some major Pfizer competitors, especially Merck. And many investment companies and hedge funds. Among the big ones, Merrill Lynch keeps coming back, over and over. And, of course, some of the companies Pfizer spied on in India are coming by.
Oh, and the International Trade Administration of the Department of Commerce seems to have taken a keen interest in the Pfizer India affair. They promote U.S. trade. Maybe they felt Pfizer's behavior in India was an embarrassment to the United States.
And, as always, the Department of Justice and the Department of Health and Human Services are visiting. Actually, lot's of visits by the Department of Health and Human Services, but I only show one of them below (click on images to see full size).
But no one stayed longer than two visitors - Institutional Investor and the law firm Davis, Polk & Wardwell . They stayed on my blog for over a day.
Davis, Polk & Wardwell is a law firm working for Pfizer, which has interviewed many Pfizer employees. Davis Polk ranked first among all U.S. law firms in a survey in which Fortune 250 law departments were asked to name the firms they rely on most in corporate transactions. They have a long history of representing institutions in complex criminal cases. Their white collar criminal practice includes the former U.S. Attorney for the Southern District of New York. They focus on advising clients in internal investigations, grand jury investigations and violations of the Foreign Corrupt Practices Act. Sounds like Pfizer came to the right place.
Most surprising of all, I think Pfizer CEO Jeff Kindler came by. Can't be 100% sure. It's been a long time since he was here. But I really think it was him . . . click on image.
I'm honored by the attention.
And the week is far from over.
Tomorrow we'll take a look at what Pfizer is doing with its most recent whistleblower and communication with the OIG.
Friday we'll check out the unusual Mea Culpa by a Pfizer lawyer.
It'll be an amazing week.